日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the lactate-metabolism related characteristics during the development of medulloblastoma through single-cell and bulk RNA-seq

通过单细胞和批量RNA测序探索髓母细胞瘤发展过程中乳酸代谢相关特征

Wang, Ce; Zhang, Rong; Li, Shenglan; Kang, Zhuang; Xia, Shaohuai; Li, Wenbin

Peroxiredoxin 1 promotes intestinal inflammation by activating the NLRP3 inflammasome in macrophages through lysosomal disruption in Crohn's disease.

过氧化物酶 1 通过溶酶体破坏激活巨噬细胞中的 NLRP3 炎症小体,从而促进克罗恩病中的肠道炎症

Li Shenglan, Xia Qiuping, He Ying, Wu Wei, Tang Damu, Deng Zhenghao, Zeng Zhijun, Tu Sha, Chen Bo, Gu Lei, Yang Xinyi, Peng Yu, Yang Huixiang, Peng Zhangzhe

Clinical validation of RNA sequencing for Mendelian disorder diagnostics

RNA测序在孟德尔遗传病诊断中的临床验证

Zhao, Sen; Macakova, Kristina; Sinson, Jefferson C; Dai, Hongzheng; Rosenfeld, Jill; Zapata, Gladys E; Li, Shenglan; Ward, Patricia A; Wang, Christiana; Qu, Chunjing; Maywald, Becky; Lee, Brendan; Eng, Christine; Liu, Pengfei

The utility of ultra-deep RNA sequencing in Mendelian disorder diagnostics

超深度RNA测序在孟德尔遗传病诊断中的应用

Zhao, Sen; Sinson, Jefferson C; Li, Shenglan; Rosenfeld, Jill A; Zapata, Gladys; Macakova, Kristina; Pena, Mezthly; Maywald, Becky; Worley, Kim C; Burrage, Lindsay C; Weisz-Hubshman, Monika; Ketkar, Shamika; Craigen, William; Emrick, Lisa; Clark, Tyson; Lithwick, Gila Yanai; Shipony, Zohar; Eng, Christine; Lee, Brendan; Liu, Pengfei

Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas

新型procaspase-3激活剂SM-1联合替莫唑胺治疗复发性高级别胶质瘤的I期临床试验

Huang, Mengqian; Kang, Zhuang; Li, Shenglan; Zhang, Botao; Xiao, Yantao; Li, Shangwei; Li, Wenbin

Bacillus amyloliquefaciens promotes cluster root formation of white lupin under low phosphorus by mediating auxin levels

枯草芽孢杆菌通过调节生长素水平促进低磷条件下白羽扇豆簇根的形成

Yang, Jinyong; Li, Shenglan; Zhou, Xiangxue; Du, Chongxuan; Fang, Ju; Li, Xing; Zhao, Jun; Ding, Fan; Wang, Yue; Zhang, Qian; Wang, Zhengrui; Liu, Jianping; Dong, Gangqiang; Zhang, Jianhua; Xu, Feiyun; Xu, Weifeng

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High-Grade Gliomas: A Multicenter, Open-Label Phase I Study

SYHA1813(一种 VEGFR 和 CSF1R 抑制剂)治疗复发性高级别胶质瘤患者:一项多中心、开放标签的 I 期研究

Kang, Zhuang; Li, Shenglan; Wang, Liang; Chen, Qianxue; Hu, Weiguo; Lei, Ting; Mao, Ying; Zhang, Jing; Xiang, Xiaojun; Wang, Qiming; He, Zhengwen; Sun, Tao; Wang, Yulei; Huang, Mengqian; Zhang, Rong; Chen, Feng; Li, Wenbin

Macrophage Migration Inhibitory Factor Suppresses Natural Killer Cell Response and Promotes Hypoimmunogenic Stem Cell Engraftment Following Spinal Cord Injury

巨噬细胞迁移抑制因子抑制自然杀伤细胞反应并促进脊髓损伤后低免疫原性干细胞移植

Li, Shenglan; Zheng, Yiyan; Xue, Haipeng; Zhang, Haiwei; Wu, Jiayun; Chen, Xiaohui; Perez Bouza, Miguel; Yi, Samantha; Zhou, Hongxia; Xia, Xugang; Zeng, Xianmin; Cao, Qi Lin; Liu, Ying

A novel compound, SYHA1813, inhibits malignant meningioma growth directly by boosting p53 pathway activation and impairing DNA repair

一种新型化合物SYHA1813,可通过增强p53通路激活和抑制DNA修复,直接抑制恶性脑膜瘤的生长。

Lan, Yanjie; Li, Shenglan; Wang, Jiachen; Yang, Xin; Wang, Can; Huang, Mengqian; Zhang, Rong; Chen, Feng; Li, Wenbin

Preliminary investigation of gut microbiota and associated metabolic pathways in the pathogenesis of primary central nervous system lymphoma

肠道菌群及其相关代谢通路在原发性中枢神经系统淋巴瘤发病机制中的初步研究

Kang, Zhuang; Zhang, Rong; Li, Shenglan; Wang, Jiachen; Huang, Mengqian; Li, Wenbin